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Recent studies have shown that the synthesis of various polysaccharides by bacteria can 
induce immune responses that are beneficial to the bacterium, the host, or both. Here, we 
discuss the diverse interactions between bacterial glycans and the host immune system.The outermost surface of many bacteria is composed of 
glycans, which often represent the first interface between 
mammalian hosts and microbes. Our understanding of 
the synthesis, assembly, and secretion of bacterial cap-
sular polysaccharides and O-antigens—which comprise 
the outermost layer of bacterial lipopolysaccharide—has 
advanced greatly in recent years. This has been accompa-
nied by a corresponding increase in our knowledge of the 
many distinct ways that these molecules interact with the 
host immune system. In fact, some of these bacterial gly-
can–host interactions actually go against the established 
paradigm of carbohydrate-induced immune responses. In 
this Minireview, we explore various interactions between 
bacterial glycans and the host immune system.
Polysaccharides: Heterogeneous Molecules 
Generating Protective Immune Responses
Bacterial capsules and O-antigens are surface polysac-
charides produced by both pathogenic and nonpathogenic 
bacterial species. These polysaccharides are usually highly 
antigenic and elicit strong antibody responses. These anti-
body responses often confer protection against subse-
quent infection. Many pathogens, such as Escherichia coli, 
Salmonella enterica, and Vibrio cholerae, are classified into 
different serological groups based on the variability of their 
O-antigens and capsular polysaccharides. In fact, E. coli is 
known to synthesize at least 173 different O-type antigens 
and 103 different capsular polysaccharides, a diversity that 
results in vast intraspecies antigenic variability. Thus, infec-
tion with a bacterium of one O-antigenic or capsular type 
often does not elicit a protective immune response against 
infection with the same species of bacterium of a different 
O-antigen or capsular type. Lack of protection against dif-
ferent bacterial serogroups is illustrated by a 1991 cholera 
pandemic in Bengal, India. The etiologic agent was a V. 
cholerae strain, designated O139 Bengal, that produced an 
O-antigen unlike those of any of the 138 previously charac-
terized V. cholerae O-antigen groups. The V. cholerae O1 
strain that was endemic in the population failed to provide 
protection against the new O139 strain, even though the 
two strains were quite similar in most other respects.The genetic basis for intraspecies diversity of O-antigens 
and capsular polysaccharides has been studied in many 
different species of bacteria. In most cases, the genes 
involved in the synthesis of a particular polysaccharide 
are clustered, often in an operon (Figure 1). Polysaccha-
ride biosynthesis regions consist of many genes whose 
products are involved in the synthesis of precursor nucle-
otide-charged monosaccharides, glycosyltransferases 
that create the linkages between monosaccharides, and 
products involved in transport, assembly, and regulation 
of polysaccharide expression. These biosynthesis loci are 
heterogeneous within bacterial species, some with sub-
stantial genetic differences and others with an alteration 
in a single gene. Genes of many of these regions were 
acquired by multiple horizontal transfer events. Even slight 
genetic alterations or rearrangements can have marked 
structural consequences and an enormous impact on 
immune recognition. In addition to marked diversity in 
the monosaccharides composing the oligosaccharide 
repeating unit, other important variations contribute to 
a polysaccharide’s biological specificity, including varia-
tions in the glycosidic linkages, the configuration of the 
anomeric center of each sugar, and the polymer’s con-
formation. These variations are exceedingly important in 
the generation of the widely diverse structures capable of 
specific interactions with the immune system.
Bacterial Glycoproteins
Once believed to be restricted to eukaryotic cells, the abil-
ity of prokaryotes to modify proteins by attaching carbo-
hydrates was recognized in groundbreaking studies on 
S layer glycoproteins (Mescher et al., 1974; Sleytr and 
Thorne, 1976). Although the field of bacterial glycoprotein 
research is still young, rapid progress has been made in 
the last few years. The surface hair-like extensions (pili) of 
Neisseria gonorrhoeae, N. meningitidis, and Pseudomonas 
aeruginosa are all glycosylated, and glycosylated flagella 
are synthesized by P. aeruginosa and Helicobacter pylori. 
A general glycosylation system has also been reported in 
Campylobacter jejuni (Szymanski et al., 1999) and Bacter-
oides spp. (Coyne et al., 2005). Studies are beginning to Cell 126, September 8, 2006 ©2006 Elsevier Inc. 847
Figure 1. Bacteroides fragilis Glycans in the Mammalian Intestine
(Left) The scattered genomic distribution of the biosynthesis loci for the eight characterized capsular polysaccharides of B. fragilis is highlighted. B. 
fragilis modulates its surface by inverting the promoters (depicted with arrows) governing capsular polysaccharide biosynthesis. The promoters are 
contained within inverted repeats (black boxes), and DNA inversion between these inverted repeats is a main mechanism dictating which polysac-
charides are expressed by individual bacteria. Each polysaccharide is depicted with a distinct color on the surface of the bacteria. (Middle) The bac-
teria and the host intestinal epithelium both express fucosylated molecules on their surfaces. Bacteroides spp. induce the expression of fucosylated 
molecules on the intestinal epithelium by somehow causing the upregulation of α1,2 fucosyltransferase mRNA. Bacteroides secrete fucosidases 
that are able to cleave the terminal fucose moieties from host-derived glycans and internalize them through the action of a fucose permease. This 
fucose can be converted to GDP-fucose, which ensures its incorporation into bacterial capsular polysaccharides and glycoproteins. (Right) B. 
fragilis colonizes the gastrointestinal tract of mammals and secretes its capsular polysaccharides into the intestinal lumen. The polysaccharide is 
endocytosed by dendritic cells that carry the antigen to the mesenteric lymph nodes. CD4+ T cells are stimulated via presentation of polysaccharides 
by the MHC II pathway and results in the production of Th1 cytokines such as INFγ, with concomitant downregulation of the Th2 cytokine IL-4. This 
Th1 response balances the Th2 skewing in germ-free animals to resemble that of conventionally colonized animals.illuminate some of the functional properties of bacterial 
glycoproteins, many of which are necessary for host inter-
actions. For example, interaction between the 45/47 kDa 
mannosylated Apa glycoproteins of Mycobacterium spp. 
and the host’s immune system elicits an immune response 
(Romain et al., 1999). Immune stimulation is dependent on 
both the presence of the glycan component and on the 
extent of glycosylation (Horn et al., 1999). As research on 
bacterial glycoproteins continues to evolve, so too will our 
knowledge of important interactions mediated by these 
molecules during bacterial association with the host.
Exchange of Glycans between Host and Bacterial 
Surfaces
A few bacteria obtain glycan molecules directly from the 
host and incorporate these molecules into their surface 
structures. These bacteria have an intimate, dependent, 
and exclusive association with mammalian hosts. Hae-
mophilus influenzae, an important human pathogen that 
causes sepsis and meningitis, scavenges sialic acid from 
the host rather than synthesizing this sugar de novo. H. 
influenzae is able to activate this host-acquired sialic 
acid to CMP-sialic acid and express it on its lipopolysac-
charide (reviewed in Vimr et al., 2004). Studies in a chin-
chilla model of middle ear infection showed that, in order 
to persist and cause infection, nontypable H. influenzae 
must acquire sialic acid from the host and use this host-
acquired sialic acid to decorate its lipopolysaccharide 
(Bouchet et al., 2003). Another analogous system involves 
the fucosylated glycoproteins and capsular polysaccha-
rides of the Bacteroides spp., which are important human 
intestinal symbionts (Figure 1). Bacteroides thetaiotaomi-848 Cell 126, September 8, 2006 ©2006 Elsevier Inc.cron produces a signal that increases the expression of 
α1,2 fucosyltransferase mRNA in intestinal epithelial cells 
of gnotobiotic mice (i.e., mice that are raised germ-free 
and then infected with specific bacteria) (Bry et al., 1996). 
This increased expression leads to an upregulation of fuc-
osylated molecules on the host epithelium. Bacteroides 
organisms synthesize multiple fucosidases that cleave 
terminal fucose residues, which can then be internalized 
by the bacteria through the action of a fucose permease. 
Once inside the bacterial cell, the fucose can either be cat-
abolized for energy or converted to the nucleotide-acti-
vated form (GDP-fucose) by the action of the bifunctional 
bacterial enzyme Fkp (Coyne et al., 2005). Activation of 
fucose to GDP-fucose by Fkp ensures that host-derived 
fucose will be incorporated into capsular polysaccharides 
or bacterial glycoproteins. This entire fucosylation proc-
ess results in a coordination of the surface architectures 
of bacterium and host and probably has significant conse-
quences for the success of Bacteroides in the mammalian 
gut. Indeed, mutant organisms that cannot incorporate 
fucose into their capsular polysaccharides and glycopro-
teins are rapidly outcompeted by wild-type bacteria in a 
mammalian intestinal colonization model.
Immune Responses to Microbial Glycans
The study of bacterial infections has clearly demonstrated 
the importance of polysaccharides as virulence factors. In 
fact, capsule production is required for virulence in numer-
ous animal models of infection. Polysaccharides contrib-
ute to virulence through several mechanisms, including 
antiphagocytic and antibacteriolytic activity, immune eva-
sion, immune modulation, and biofilm production.
Escaping Immune Surveillance
Polysaccharide-deficient bacterial strains are typically 
killed through the action of normal serum and polymorpho-
nuclear leukocytes (PMNs) without specific antibodies. Kill-
ing of encapsulated bacteria by serum and PMNs requires 
coating these bacteria (opsonization) with both comple-
ment molecules and antibodies. Complement deposition 
on the organism’s surface in the absence of specific anti-
bodies is mediated by either the alternative complement 
pathway involving soluble multivalent lectins that activate 
the complement cascade, by the mannan binding lectin 
pathway, or by a recently described interaction with C-
lectin receptors (Kang et al., 2006). Certain carbohydrate 
structures, such as sialic acids, which are common on the 
capsules of pathogens (e.g., Neisseria meningitidis), inhibit 
activation of complement in the absence of specific anti-
bodies and thereby allow these microbes to survive in the 
bloodstream. The induction of specific antibodies through 
immunization, with consequent complement deposition on 
an organism, is a major factor in successful vaccination.
Immune Evasion by Molecular Mimicry
The actual glycan composition or structure is crucial for 
particular interactions with the host immune system as 
exemplified by bacteria that synthesize polysaccharides 
that mimic host molecules to evade host immunity. In 
mammalian cells, hyaluronic acid is an important com-
ponent of the extracellular matrix and is critical to many 
cellular processes. The hyaluronic acid capsule of group 
A streptococci is a clear example of a mammalian struc-
ture mimicked by a bacterial polysaccharide to evade the 
host immune system. A second example is provided by the 
sialic acid capsule of the bacterium Neisseria meningitidis 
group B. Unlike the α2→9 linked sialic acid homopolymer 
that makes up the meningococcal group C polysaccha-
ride—which is highly immunogenic in human adults and 
has served as a successful vaccine—the α2→8 sialic acid 
homopolymer of group B has completely failed as a vac-
cine. Its lack of immunogenicity in humans is attributed to 
its structural similarity to glycoproteins in human fetal brain 
tissues (Finne et al., 1983). These examples illustrate how 
the structure of these polymers can inhibit a protective 
immune response, with a favorable outcome for bacteria.
Zwitterionic Polysaccharides and Immunity
The zwitterionic polysaccharides (ZPSs; polysaccharides 
with both a positive and negative charge) of B. fragilis and 
type 1 Streptococcus pneumoniae provide a very different 
example of how a structural motif of a polysaccharide is 
essential for its biological function. This interesting class of 
bacterial polysaccharides has proven to be an exception 
to the paradigm for how carbohydrates induce immune 
responses. In general, polysaccharides are classic T 
cell–independent antigens; therefore, they do not induce 
activation of helper T cells that then stimulate IgG switch-
ing in B cells, nor do they elicit immunologic memory (a 
deficiency evidenced by a failure of booster immunization 
with pure polysaccharide vaccines). To enlist T cell help, 
polysaccharides have been coupled to protein carriers in 
the production of successful vaccines that induce produc-tion of IgG antibodies and memory B cells. Presumably, 
the carbohydrate in these glycoconjugate vaccines binds 
to polysaccharide-specific B cells, and then helper T cells 
are activated by the processing and presentation of anti-
genic peptides contained in the conjugate by major histo-
compatibility class II (MHC II) molecules.
Recently, ZPSs have been shown to be processed and 
presented by the MHC II pathway (Cobb et al., 2004), 
which had previously been thought to be reserved for 
proteins only. ZPSs are taken into the endosome of 
the antigen-presenting cell (APC) and are processed 
to a much smaller molecular size. ZPS processing is 
dependent on nitric oxide (NO) and does not involve gly-
cosidases. The chemistry of the interactions of reactive 
oxygen or nitrogen species with ZPSs has not yet been 
delineated. Aside from the NO-dependent mechanism 
for reducing the molecular size, the ZPSs follow the 
same MHC II vesicular pathway as conventional protein 
antigens before being presented to the αβ T cell receptor 
in the context of the MHC II molecule.
Glycans and Long-Term Host-Bacterial Interactions
Clearly, polysaccharides confer advantages to bacterial 
pathogens in their interactions with the host but can also 
serve as immunodominant antigens against which the 
host can often mount a protective response. However, the 
role of bacterial polysaccharides in bacterial-host rela-
tionships that are not transient infectious interactions but 
rather are long-term or commensal interactions is not well 
defined. Production of polysaccharides by some com-
mon commensal bacteria surpasses that of many patho-
genic bacteria. Of the hundreds of bacterial species that 
inhabit the human intestine, the Bacteroides are among 
the most abundant. Of all bacteria analyzed to date, 
Bacteroides fragilis synthesizes the greatest number of 
capsular polysaccharides per organism (at least eight) 
(Figure 1). B. fragilis has evolved an elaborate mechanism 
using “phase variation” for extensively alterating its sur-
face whereby each polysaccharide undergoes a revers-
ible on-off phenotype. Phase variation of seven B. fragilis 
polysaccharides is controlled by DNA inversions of the 
promoter regions of their biosynthesis loci, placing them 
in the correct or incorrect orientation for transcription of 
the downstream polysaccharide biosynthesis genes (Kri-
nos et al., 2001). By this mechanism, B. fragilis dynami-
cally modulates polysaccharide expression to create 
completely distinct surface architectures. It is possible 
that phase variation of such an extensive array of surface 
polysaccharides guarantees the long-term existence of 
a microbial population best fit to survive in the changing 
milieu of the gut, whether by immune evasion, by resist-
ance to phage infection, by creation of a competitive 
advantage in colonization, or by favorable interactions 
with other members of the intestinal microbiota.
In addition to conferring advantages on bacteria, the 
capsular polysaccharides of B. fragilis are important in 
maintaining the health of the host. Polysaccharide A (PSA), 
the most abundant of the eight B. fragilis polysaccharides, Cell 126, September 8, 2006 ©2006 Elsevier Inc. 849
may be involved in the maturation of the host immune sys-
tem (Figure 1) (Mazmanian et al., 2005). Although mice born 
and maintained in a germ-free environment have defects 
in their intestinal immune system, recent work has shown 
that they also have systemic immune deficiencies. Several 
immunologic deficits normally found in germ-free mice can 
be corrected by introducing B. fragilis (“mono-association”) 
into these mice. The immune systems of mice mono-asso-
ciated with wild-type B. fragilis were compared with those 
of mice mono-associated with the same strain that has a 
deletion of the genetic locus responsible for synthesizing 
PSA (∆PSA). With respect to several important immuno-
logic parameters, wild-type mono-associated mice were 
identical to conventionally colonized mice that were born 
and maintained under nonsterile conditions. In both con-
ventionally colonized mice and wild-type mono-associ-
ated mice, about 17% of splenic lymphocytes were CD4+ T 
cells compared to 11% for both germ-free mice and mice 
mono-associated with the ∆PSA deletion mutant. Splenic 
CD4+ T cells from conventionally colonized mice and wild-
type mono-associated mice produced similar levels of 
interferon γ, whereas there was markedly less production 
of this cytokine by cells from ∆PSA-mono-associated and 
germ-free animals. Interestingly, the conventionally colo-
nized and wild-type mono-associated mice produced low 
levels of interleukin-4, whereas the ∆PSA-mono-associ-
ated and germ-free animals produced high levels of this 
cytokine. Therefore, the CD4+ T cell subtypes of germ-free 
and ∆PSA-mono-associated mice were skewed toward T 
helper 2 (Th2) cells because of low levels of interferon γ (Th1 
cytokine) and high levels of IL-4 (Th2 cytokine). In contrast, 
wild-type mono-associated and conventionally colonized 
mice have a normal balance of Th1 and Th2 cells. Finally, 
the spleen and thymus glands of ∆PSA-mono-associ-
ated mice exhibited histological abnormalities, whereas 
wild-type mono-associated mice had normal splenic and 
thymic histology. Remarkably, these profound effects on 
T cell lineages were all mediated by a carbohydrate. These 
findings show that bacterial carbohydrates are very impor-
tant in directing the maturation of the host immune system. 
In fact, they appear to be the archetypal molecules of com-
mensals that provide the molecular stimulus for symbiosis 
between bacteria and their hosts.
The bacterium Helicobacter pylori often has a long-term 
association with mammalian hosts—in this case, as a per-
sistent colonizer of the stomach that sometimes causes 
ulcers and occasionally stomach cancer. As with B. fra-
gilis, a glycan molecule of H. pylori appears to modulate 
the host’s immune response. H. pylori produce O-antigens 
that are fucosylated and resemble Lewis blood group anti-
gens. The expression of the Lewis blood group antigens on 
the surface lipopolysaccharides of H. pylori is phase vari-
able and is dictated by slip-strand mispairing in the cod-
ing regions of fucosyltransferase genes. Therefore, a given 
strain of H. pylori will manifest as a mixed population with 
regard to the expression of Lewis blood group antigens. 
Lewis antigen-positive H. pylori strains bind to the C type 
lectin DC-SIGN that is present on host dendritic cells, and 850 Cell 126, September 8, 2006 ©2006 Elsevier Inc.this binding inhibits naive T cells from differentiating into 
Th1 cells (Bergman et al., 2004). Lewis antigen-negative 
strains of H. pylori fail to bind to dendritic cells and thus 
promote the development of naive T cells into Th1 cells that 
release proinflammatory molecules, creating an unfavora-
ble environment for colonization. The variable expression 
of Lewis antigens may balance the Th1 and Th2 responses 
to create niches where H. pylori can colonize the host with-
out producing disease (Bergman et al., 2006).
In conclusion, the immense structural diversity of bac-
terial glycans and their presence on both pathogens and 
commensals inhabiting diverse host sites contribute to the 
many disparate interactions of these molecules with the 
host immune system. In addition to the role of polysaccha-
rides as key virulence factors of bacterial pathogens, their 
importance for both host and bacteria in long-term com-
mensal interactions is beginning to be appreciated. The 
ability not only to induce or suppress immune responses 
but also to modulate the mammalian immune response 
both systemically and locally demonstrates the great func-
tional diversity of these important bacterial molecules.
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